Emergence Delirium in Perioperative Pediatric Care: A Review of Current Evidence and New Directions
Abstract Emergence delirium (ED) is defined as psychomotor agitation and delirium that typically occurs within 45 min from emergence of anesthesia. Preoperative patient conditions such as anxiety and confusion are risk factors for the development of postoperative ED. Common signs of ED are general non-purposeful resistive movements such as kicking, pulling, flailing as well as lack of eye contact and general lack of awareness of surroundings. The use of volatile anesthetics (VA) is contributory, while the use of total intravenous anesthetic techniques (TIVA) may help to reduce the incidence of emergence delirium. Furthermore, various pharmacologic strategies and alternatively non-pharmacologic strategies have been demonstrated to further diminish its occurrence. The objective of this manuscript is to provide a comprehensive review of anesthetic considerations for pediatric ED and to provide an update on techniques that have been found to be effective in reducing the overall risk of developing postoperative ED in pediatric patients..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Advances in therapy - 37(2020), 5 vom: 09. Apr., Seite 1897-1909 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Urits, Ivan [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Anesthesia |
| Anmerkungen: |
© Springer Healthcare Ltd., part of Springer Nature 2020 |
|---|
| doi: |
10.1007/s12325-020-01317-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2035841070 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2035841070 | ||
| 003 | DE-627 | ||
| 005 | 20230513091243.0 | ||
| 007 | tu | ||
| 008 | 200819s2020 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12325-020-01317-x |2 doi | |
| 035 | |a (DE-627)OLC2035841070 | ||
| 035 | |a (DE-He213)s12325-020-01317-x-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.40$jPharmazie$jPharmazeutika |2 bkl | ||
| 100 | 1 | |a Urits, Ivan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Emergence Delirium in Perioperative Pediatric Care: A Review of Current Evidence and New Directions |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Springer Healthcare Ltd., part of Springer Nature 2020 | ||
| 520 | |a Abstract Emergence delirium (ED) is defined as psychomotor agitation and delirium that typically occurs within 45 min from emergence of anesthesia. Preoperative patient conditions such as anxiety and confusion are risk factors for the development of postoperative ED. Common signs of ED are general non-purposeful resistive movements such as kicking, pulling, flailing as well as lack of eye contact and general lack of awareness of surroundings. The use of volatile anesthetics (VA) is contributory, while the use of total intravenous anesthetic techniques (TIVA) may help to reduce the incidence of emergence delirium. Furthermore, various pharmacologic strategies and alternatively non-pharmacologic strategies have been demonstrated to further diminish its occurrence. The objective of this manuscript is to provide a comprehensive review of anesthetic considerations for pediatric ED and to provide an update on techniques that have been found to be effective in reducing the overall risk of developing postoperative ED in pediatric patients. | ||
| 650 | 4 | |a Anesthesia | |
| 650 | 4 | |a Emergence agitation | |
| 650 | 4 | |a Emergence delirium | |
| 650 | 4 | |a Pharmacotherapy | |
| 650 | 4 | |a Pediatrics | |
| 650 | 4 | |a Post anesthetic excitement | |
| 700 | 1 | |a Peck, Jacquelin |4 aut | |
| 700 | 1 | |a Giacomazzi, Stephen |4 aut | |
| 700 | 1 | |a Patel, Riki |4 aut | |
| 700 | 1 | |a Wolf, John |4 aut | |
| 700 | 1 | |a Mathew, Denzil |4 aut | |
| 700 | 1 | |a Schwartz, Ruben |4 aut | |
| 700 | 1 | |a Kassem, Hisham |4 aut | |
| 700 | 1 | |a Urman, Richard D. |4 aut | |
| 700 | 1 | |a Kaye, Alan D. |4 aut | |
| 700 | 1 | |a Viswanath, Omar |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Advances in therapy |d Springer Healthcare, 1984 |g 37(2020), 5 vom: 09. Apr., Seite 1897-1909 |w (DE-627)168085585 |w (DE-600)632651-1 |w (DE-576)482252200 |x 0741-238X |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2020 |g number:5 |g day:09 |g month:04 |g pages:1897-1909 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s12325-020-01317-x |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 936 | b | k | |a 44.40$jPharmazie$jPharmazeutika |q VZ |0 106423304 |0 (DE-625)106423304 |
| 951 | |a AR | ||
| 952 | |d 37 |j 2020 |e 5 |b 09 |c 04 |h 1897-1909 | ||